ABSTRACT
A key step of Canonical Nonhomologous End Joining (C-NHEJ) is synapsis of DNA double strand break (DSB) ends for ligation. The DNA-PKcs dimer mediates synapsis in a long-range complex with DSB ends remaining apart, whereas the XLF homodimer can mediate synapsis in both long-range and short-range complexes. Recent structural studies found the PAXX homodimer may also facilitate synapsis in long-range complexes with DNA-PKcs via its interactions with Ku70. Thus, we examined the influence of PAXX in C-NHEJ of chromosomal DSBs, which we compared to another Ku-binding factor, MRI. Using EJ of blunt DSBs with Cas9 reporters as a readout for C-NHEJ, we found that PAXX and/or MRI are dispensable. However, when combined with disruption of DNA-PKcs, particularly with DNA-PKcs kinase inhibition, PAXX becomes important for blunt DSB EJ. In contrast, while DNA-PKcs is also important to suppress short deletion mutations with microhomology, this effect is not magnified with PAXX loss. MRI loss had no effect combined with DNA-PKcs disruption, but becomes important for blunt DSB EJ when combined with disruption of XLF, as is PAXX. Finally, XLF loss causes an increase in larger deletions compared to DNA-PKcs inhibition, which is magnified with combined loss of MRI. Altogether, we suggest that PAXX promotes DSB end synapsis during C-NHEJ in a manner that is partially redundant with DNA-PKcs and XLF, whereas MRI appears to be mainly important in the context of XLF disruption.
SIGNIFICANCE STATEMENT Canonical Nonhomologous End Joining (C-NHEJ) is a DNA double strand break repair pathway that can repair diverse types of DNA ends, but is prone to causing genetic mutations. In particular, C-NHEJ can cause insertion or deletion mutations that can cause human disease. Therefore, it is critical to understand the mechanisms of C-NHEJ, including and how various factors within the pathway affect repair outcomes. In this study, we elucidate the role of factors PAXX and MRI during chromosomal EJ and their interplay with the C-NHEJ factors DNA-PKcs and XLF.
Competing Interest Statement
The authors have declared no competing interest.
